Age and the Risk of Paclitaxel‐Induced Neuropathy in Women with Early‐Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101

PURPOSE. A few previous studies report a direct relationship between older age and chemotherapy‐induced neuropathy. This study further evaluated this adverse event's age‐based risk. METHODS. CALGB 40101 investigated adjuvant paclitaxel (80 mg/m(2) once per week or 175 mg/m(2) every 2 weeks) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Barginear, Myra, Dueck, Amylou C., Allred, Jacob B., Bunnell, Craig, Cohen, Harvey J., Freedman, Rachel A., Hurria, Arti, Kimmick, Gretchen, Le‐Rademacher, Jennifer G., Lichtman, Stuart, Muss, Hyman B., Shulman, Lawrence N., Copur, M. Sitiki, Biggs, David, Ramaswamy, Bhuvaneswari, Lafky, Jacqueline M., Jatoi, Aminah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Geriatric Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516126/
https://www.ncbi.nlm.nih.gov/pubmed/30409792
http://dx.doi.org/10.1634/theoncologist.2018-0298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516126/
https://www.ncbi.nlm.nih.gov/pubmed/30409792
http://dx.doi.org/10.1634/theoncologist.2018-0298

Ejemplares similares